Document is current
Any future updates will be listed below
-
Authors
Vranken, Nousjka P. A. https://orcid.org/0000-0002-6547-7008
Li, Xinyu https://orcid.org/0000-0002-0225-6937
Bouman, Heleen https://orcid.org/0000-0002-2164-4011
Mourmans, Sanne G. J. https://orcid.org/0000-0003-3408-6511
Achten, Anouk https://orcid.org/0009-0005-0763-7551
Barandiarán Aizpurua, Arantxa https://orcid.org/0000-0002-3448-5531
Brunner-La Rocca, Hans-Peter https://orcid.org/0000-0002-4356-8566
Knackstedt, Christian https://orcid.org/0000-0002-5457-3010
van Empel, Vanessa P. M. https://orcid.org/0000-0002-6864-0296
Weerts, Jerremy https://orcid.org/0000-0002-9369-3453
- License Information
-
More Information
Article History
Received: 20 February 2025
Accepted: 24 March 2025
First Online: 5 April 2025
Declarations
:
: The study was approved by the Institutional Review Board and performed according to the principles of the Declaration of Helsinki. All patients provided written informed consent.
: Not applicable.
: A.A. reports grants and personal fees from Pfizer and Alnylam, outside the submitted work paid to the institution. H.P.B.L.R. reports grants, personal fees and non-financial support from Roche Diagnostics, personal fees from Novartis, personal fees from AstraZeneca, grants and personal fees from Vifor, personal fees from Boehringer-Ingelheim, outside the submitted work. C.K. has received speaker honoraria from Pfizer, BMS, paid to the Maastricht University Medical Center, and consulting fees from Bayer, Pfizer, Novartis, BMS, and Alnylam paid to the Maastricht University Medical Center. V.v.E. reports grants and personal fees from Bayer, grants from Roche Diagnostics, grants from Vifor, personal fees from Novartis, personal fees from AstraZeneca, personal fees from Merck, personal fees from Janssen, outside the submitted work. J.W. reports grants from Corvia Medical, CSL Vifor, and Boehringer Ingelheim, outside the submitted work. The other authors declare that they have no conflict of interest.
